Trends in clinical and oncological outcomes of robot-assisted radical prostatectomy before and after the 2012 US Preventive Services Task Force recommendation against PSA screening: a decade of experience
- PMID: 32173990
- DOI: 10.1111/bju.15051
Trends in clinical and oncological outcomes of robot-assisted radical prostatectomy before and after the 2012 US Preventive Services Task Force recommendation against PSA screening: a decade of experience
Abstract
Objective: To assess the influence of the 2012 US Preventive Services Task Force (USPSTF) recommendation against prostate-specific antigen (PSA)-based screening on oncological and functional outcomes following robot-assisted laparoscopic prostatectomy (RALP).
Materials and methods: We retrospectively analysed patients who underwent RALP between 2008 and 2018 with a minimum of 12-month follow-up from a prospectively collected institutional review board-approved database. The impact of the USPSTF recommendation against PSA screening on our surgical outcomes was assessed using a logistic regression model using two groups comprising patients treated before/after the USPSTF statement and indicating time trends for each successive year.
Results: The mean preoperative PSA increased from 6.0 to 7.4 ng/mL after the USPSTF recommendation. We detected statistically significant time-trend changes after 2012, including an increase in the positive slope of Gleason ≥3 + 4 or ≥pT3 disease. We detected a fall in bilateral full nerve-sparing and an increase in partial nerve-sparing. The total positive surgical margin (PSM) rate increased after the USPSTF recommendation; however, PSM rates pertinent to each pathological stage did not change significantly after 2012. There was a significant negative trend change in the postoperative 12-month continence and potency rates, indicating a breakpoint in functional outcomes after 2012. We detected a 1.7-fold increase in 12-month biochemical recurrence (BCR) rates. The 12-month BCR, potency and continence rates were maintained in young (<55 years) patients with a Sexual Health Inventory for Men score >22 and low-volume disease.
Conclusion: Since the USPSTF's recommendation in 2012, we have seen a significant increase in the incidence of high-risk disease that has forced us to modify our approach to the procedure and the grade of nerve-sparing used, leading to a wider resection, in order to reduce PSMs. This has led to a decrease in postoperative functional recovery. Patients with favourable characteristics had good outcomes before and after the USPSTF's recommendation, implying that the quality of surgery did not change over time.
Keywords: PSA screening; RALP outcomes; USPSTF recommendation; clinical trends.
© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.
References
-
- Hugosson J, Roobol MJ, Månsson M et al. A 16-yr follow-up of the European randomized study of screening for PCa. Eur Urol 2019; 76: 43-51
-
- Prostate Cancer - Cancer Stat Facts [Internet]. Available at: https://seer.cancer.gov/statfacts/html/prost.html. Accessed November 2019
-
- Jacobsen SJ, Katusic SK, Bergstralh EJ et al. Incidence of PCa diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA J Am Med Assoc 1995; 274: 1445-9
-
- Moyer VA. Screening for PCa: U.S. Preventive Services Task Force recommendation statement. Ann Internal Med 2012; 157: 120-34
-
- Shah N, Ioffe V, Huebner T, Hristova I. Prostate biopsy characteristics: a comparison between the pre- and post-2012 United States Preventive Services Task Force (USPSTF) PCa screening guidelines. Rev Urol 2018; 20: 77-83
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous